Skip to content
The Biotechnology Innovation Organization (BIO), along with its members, sent a letter to Congressional leadership earlier this month urging for legislative action to be […]
Why Congress must repeal the R&D amortization provision Read More »
In a groundbreaking move towards advancing gene therapy research and treatment options for rare diseases, the Foundation for the National Institutes of Health (FNIH)
National Women’s Health Week brought a groundbreaking development: the approval of a new treatment option for hot flashes caused by menopause. On May 12,
FDA approves new treatment for menopause hot flashes Read More »
Pharmacy benefit managers (PBMs) and hospitals using the 340B program were in the crosshairs on May 17 as the House Energy & Commerce Health
E&C Health Subcommittee advances bills to bring transparency to PBMs and 340B Read More »
Reported research from May 18, 2022 Clinical trials currently underway may soon tell us whether the mRNA vaccines against COVID-19 could pave the way
HIV Vaccine Awareness Day: 2023 updates on progress Read More »
May 18 is Global Accessibility Awareness Day (GAAD), which takes place every third Thursday of May each year and is an important reminder of
Global Accessibility Awareness Day: an annual call to action Read More »
Inventions like AI-developed drugs belong to the human inventor, says the Biotechnology Innovation Organization (BIO) in comments to the U.S. Patent and Trademark Office
Who owns drugs developed with AI? Read More »
The National Human Genome Research Institute (NHGRI) released the “pangenome,” the updated map of the human genome, which includes more diverse DNA than ever
Why the updated map of the human genome matters Read More »
May 14-20 is Food Allergy Awareness Week, which brings to light the 32 million Americans suffering with food allergies. However, biotechnology can help reduce
Food Allergy Awareness Week: How biotech addresses food allergies Read More »
The new plan to reform European Union pharmaceutical legislation falls short on data and market protections but includes positive efforts to streamline drug approval
Plan to reform EU pharma law elicits kudos and concerns from BIO experts Read More »
